NCT07076615View on ClinicalTrials.gov

The Effect of Dapagliflozin on Patients With Cardiomyopathy

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Acute Decompensated Heart Failure (ADHF)
Interventions
DRUG

Dapagliflozin (DAPA)

Receives dapagliflozin 10 mg once daily + standard intravenous diuretic therapy

DRUG

Diuretic

Arm B (Control Group): Receives standard intravenous diuretic therapy alone

Trial Locations (1)

Unknown

RECRUITING

Cairo University, Cairo

All Listed Sponsors
collaborator

Cairo University

OTHER

lead

May Mohamed Abdalla

OTHER